Peter Cheverton
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 10%
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 2
-
- Cancer therapeutics and mechanisms 4
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- D M Dent (1 shared paper)I. D. Werner (1 shared paper)P. Brice (1 shared paper)Ben Novis (1 shared paper)J. Wanders (3 shared papers)John P. Fruehauf (1 shared paper)Kevin B. Kim (1 shared paper)Daniel S. Chen (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)Bone Marrow Transplantation (2 papers)Lung Cancer (2 papers)Biology of Blood and Marrow Transplantation (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter Cheverton
18 papers receiving 554 citations
Peers
Comparison fields: 5 of 65
- Oncology 285
- Gastroenterology 32
- Pulmonary and Respiratory Medicine 124
- Biomaterials 56
- Molecular Biology 238
Countries citing papers authored by Peter Cheverton
This map shows the geographic impact of Peter Cheverton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cheverton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cheverton more than expected).
Fields of papers citing papers by Peter Cheverton
This network shows the impact of papers produced by Peter Cheverton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cheverton. The network helps show where Peter Cheverton may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Cheverton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 157 | |
| 2 | 1979 | 92 | |
| 3 | 2005 | 69 | |
| 4 | 2004 | 60 | |
| 5 | 2004 | 45 | |
| 6 | 2018 | 37 | |
| 7 | 2000 | 34 | |
| 8 | 2019 | 23 | |
| 9 | 2003 | 18 | |
| 10 | 2005 | 17 | |
| 11 | 2003 | 16 | |
| 12 | 2004 | 8 | |
| 13 | 2005 | 5 | |
| 14 | 1999 | 4 | |
| 15 | 2000 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2010 | 1 |
About Peter Cheverton
Peter Cheverton is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Hematology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 593 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Neutropenia and Cancer Infections (2 papers), Acute Myeloid Leukemia Research (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Oncology (285 citations), Gastroenterology (32 citations), Pulmonary and Respiratory Medicine (124 citations), Biomaterials (56 citations) and Molecular Biology (238 citations). Peter Cheverton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include D M Dent, I. D. Werner, P. Brice, Ben Novis, J. Wanders, John P. Fruehauf, Kevin B. Kim, Daniel S. Chen, Gerald P. Linette and David F. McDermott. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Bone Marrow Transplantation, Lung Cancer and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.